Last updated: February 16, 2026
What is Aclometasone Dipropionate?
Aclometasone Dipropionate is a synthetic corticosteroid used topically for allergic rhinitis, eczema, and other inflammatory skin conditions. It is available as nasal spray and topical formulations. The drug is marketed primarily by pharmaceutical companies in the US, Europe, and Asia.
Market Size and Growth Trends
Global Market Valuation (2022): Approximately $480 million
Projected CAGR (2023-2028): 4.2% (Source: Grand View Research [1])
Key Markets: North America (40%), Europe (30%), Asia-Pacific (20%), Rest of the world (10%)
Drivers:
- Increasing prevalence of allergic rhinitis and atopic dermatitis.
- Growing awareness about corticosteroid-based therapies.
- Introduction of generic formulations reducing treatment costs.
Challenges:
- Competition from other corticosteroids such as fluticasone and mometasone.
- Stringent regulatory requirements for nasal sprays and topical drugs.
- Limited patent protection due to the availability of generics.
Patent and Regulatory Status
- Original patents expired between 2015 and 2018.
- Several pharmaceutical firms produce generics.
- No recent patents filed for novel formulations or delivery devices.
Competitive Landscape
| Company |
Product Name |
Market Share (Estimated) |
Key Differentiator |
| Teva Pharmaceuticals |
Aclometa (Nasal Spray) |
35% |
Cost-effective generic |
| Mylan |
Mometasone nasal spray |
25% |
Wide distribution network |
| Sandoz |
Systenex (Topical) |
10% |
Focus on dermatological indications |
| Others |
Various generics |
30% |
Price competition |
Price Projections
Current Average Wholesale Price (AWP):
- Nasal spray: $25 per 30-ml bottle
- Topical cream: $15 per 30g tube
Short-Term (Next 1-2 years):
- Prices expected to remain stable due to generic competition.
- Slight decrease (~5%) expected as new generics enter the market.
Medium-Term (3-5 years):
- Price reductions of 10-15% likely, driven by increased competition.
- Possible price stabilization if novel delivery systems are introduced.
Long-Term (over 5 years):
- Prices may decline further, approaching $10-12 for nasal spray and $8-10 for topical formulations, depending on market penetration and regulation.
Factors Influencing Price Changes
- Entry of biosimilars or new formulations.
- Regulatory policies impacting drug pricing.
- Patent protections or market exclusivities granted for novel delivery methods.
- Changes in procurement policies within principal markets (e.g., government tenders).
Regulatory and Policy Impact on Future Pricing
- USFDA and EMA have not introduced significant restrictions specific to Aclometasone Dipropionate.
- Overall drug price controls in certain markets may influence discounts and rebates.
- Centralized approval frameworks expedite generic approvals, pressuring existing prices downward.
Key Takeaways
- The global Aclometasone Dipropionate market was valued at nearly $480 million in 2022.
- Growth is steady, driven by rising allergy and skin condition prevalence.
- The price of branded and generic formulations is projected to decrease by approximately 10-15% over the next five years.
- Market competition, patent expiration, and regulatory policies heavily influence price trajectories.
- Future potential for price stabilization exists if innovative delivery systems or formulations accrue regulatory approval.
FAQs
1. What are the primary indications for Aclometasone Dipropionate?
It treats allergic rhinitis, eczema, and other inflammatory skin conditions, administered as nasal spray or topical formulations.
2. How competitive is the Aclometasone Dipropionate market?
Market competition is strong, with several generics available, reducing prices and profit margins.
3. What factors could significantly alter the market outlook?
Entry of new formulations, regulatory changes, and patent protections for innovative delivery systems.
4. Which regions are driving the largest market share?
North America leads with 40%, followed by Europe at 30%, and Asia-Pacific at 20%.
5. What is the outlook for individual pricing over the next five years?
Prices are expected to decline gradually, with nasal spray reducing from around $25 to approximately $10-12, and topical formulations from $15 to $8-10.
References
[1] Grand View Research. "Corticosteroids Market Size, Share & Trends Analysis." 2022.
